Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogram

Hepatology

Volumn 64, Issue 2, 2016, Pages 684-685

  Targher, Giovanni ^a   Byrne, Christopher D ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

ADULT; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAROTID ARTERIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84979020940     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28306     Document Type: Letter

References (3)

1. Wong VW, Wong GL, Yeung JC, Fung CY, Chan JK, Chang ZH, et al. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: a prospective cohort study. Hepatology 2016;63:754-763.
2. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut. 2011;60:1721-1727.
3. Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl.):S47-S64.